OMERS ADMINISTRATION Corp Buys 4,527 Shares of Docusign Inc. $DOCU

Key Points

• OMERS ADMINISTRATION Corp increased its stake in Docusign Inc. by 17.9%, holding 29,809 shares worth approximately $2.43 million as of the latest SEC filing.
• Several institutional investors have also increased their positions in Docusign, contributing to 77.64% of the company's stock being held by institutional and hedge funds.
• Wall Street analysts have cut their price targets for Docusign stock, with a consensus rating of "Hold" and target price adjusted to $89.77.

OMERS ADMINISTRATION Corp raised its stake in Docusign Inc. (NASDAQ:DOCU - Free Report) by 17.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,809 shares of the company's stock after acquiring an additional 4,527 shares during the period. OMERS ADMINISTRATION Corp's holdings in Docusign were worth $2,426,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in DOCU. Integrated Wealth Concepts LLC lifted its holdings in shares of Docusign by 57.2% in the fourth quarter. Integrated Wealth Concepts LLC now owns 7,805 shares of the company's stock worth $702,000 after acquiring an additional 2,841 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in Docusign by 222.9% during the 4th quarter. The Manufacturers Life Insurance Company now owns 172,753 shares of the company's stock worth $15,537,000 after purchasing an additional 119,245 shares in the last quarter. Northern Trust Corp lifted its stake in Docusign by 77.2% in the 4th quarter. Northern Trust Corp now owns 1,984,378 shares of the company's stock valued at $178,475,000 after purchasing an additional 864,408 shares during the last quarter. Utah Retirement Systems boosted its position in Docusign by 0.6% in the fourth quarter. Utah Retirement Systems now owns 33,587 shares of the company's stock valued at $3,021,000 after buying an additional 200 shares in the last quarter. Finally, Comerica Bank boosted its position in Docusign by 193.6% in the fourth quarter. Comerica Bank now owns 93,394 shares of the company's stock valued at $8,400,000 after buying an additional 61,589 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.

Insider Buying and Selling

In related news, Director Teresa Briggs sold 534 shares of Docusign stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $74.37, for a total transaction of $39,713.58. Following the transaction, the director owned 8,805 shares of the company's stock, valued at $654,827.85. The trade was a 5.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Allan C. Thygesen sold 40,000 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the transaction, the chief executive officer owned 143,983 shares in the company, valued at approximately $11,160,122.33. This trade represents a 21.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 78,552 shares of company stock valued at $5,983,631. 1.66% of the stock is owned by company insiders.

Docusign Stock Performance

Shares of DOCU stock traded down $2.59 during trading hours on Tuesday, hitting $74.07. 3,114,227 shares of the company were exchanged, compared to its average volume of 2,571,399. The company has a 50 day simple moving average of $75.46 and a two-hundred day simple moving average of $79.59. The firm has a market cap of $14.97 billion, a P/E ratio of 14.00, a P/E/G ratio of 28.61 and a beta of 1.02. Docusign Inc. has a fifty-two week low of $54.31 and a fifty-two week high of $107.86.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.09. Docusign had a return on equity of 14.27% and a net margin of 36.50%.The company had revenue of $763.65 million for the quarter, compared to analyst estimates of $748.79 million. During the same period in the prior year, the firm earned $0.82 earnings per share. Docusign's revenue for the quarter was up 7.6% on a year-over-year basis. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, sell-side analysts expect that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its board has authorized a stock repurchase program on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 6.6% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's board believes its stock is undervalued.

Analyst Upgrades and Downgrades

DOCU has been the topic of a number of research reports. Robert W. Baird reduced their target price on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a report on Friday, June 6th. Wall Street Zen cut shares of Docusign from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Morgan Stanley decreased their price objective on Docusign from $92.00 to $86.00 and set an "equal weight" rating for the company in a report on Friday, June 6th. UBS Group cut their target price on Docusign from $85.00 to $80.00 and set a "neutral" rating on the stock in a report on Friday, June 6th. Finally, Wedbush decreased their price target on Docusign from $100.00 to $85.00 and set a "neutral" rating for the company in a research note on Thursday, June 12th. Four equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $89.77.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.